Literature DB >> 20841510

A novel form of human STAT1 deficiency impairing early but not late responses to interferons.

Xiao-Fei Kong1, Michael Ciancanelli, Sami Al-Hajjar, Laia Alsina, Timothy Zumwalt, Jacinta Bustamante, Jacqueline Feinberg, Magali Audry, Carolina Prando, Vanessa Bryant, Alexandra Kreins, Dusan Bogunovic, Rabih Halwani, Xin-Xin Zhang, Laurent Abel, Damien Chaussabel, Saleh Al-Muhsen, Jean-Laurent Casanova, Stéphanie Boisson-Dupuis.   

Abstract

Autosomal recessive STAT1 deficiency is associated with impaired cellular responses to interferons and susceptibility to intracellular bacterial and viral infections. We report here a new form of partial STAT1 deficiency in 2 siblings presenting mycobacterial and viral diseases. Both carried a homozygous missense mutation replacing a lysine with an asparagine residue at position 201 (K201N) of STAT1. This mutation causes the abnormal splicing out of exon 8 from most STAT1 mRNAs, thereby decreasing (by ~ 70%) STAT1 protein levels. The mutant STAT1 proteins are not intrinsically deleterious, in terms of tyrosine phosphorylation, dephosphorylation, homodimerization into γ-activating factor and heterotrimerization into ISGF-3, binding to specific DNA elements, and activation of the transcription. Interestingly, the activation of γ-activating factor and ISGF3 was impaired only at early time points in the various cells from patient (within 1 hour of stimulation), whereas sustained impairment occurs in other known forms of complete and partial recessive STAT1 deficiency. Consequently, delayed responses were normal; however, the early induction of interferon-stimulated genes was selectively and severely impaired. Thus, the early cellular responses to human interferons are critically dependent on the amount of STAT1 and are essential for the appropriate control of mycobacterial and viral infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20841510      PMCID: PMC3031383          DOI: 10.1182/blood-2010-04-280586

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells.

Authors:  W E Thierfelder; J M van Deursen; K Yamamoto; R A Tripp; S R Sarawar; R T Carson; M Y Sangster; D A Vignali; P C Doherty; G C Grosveld; J N Ihle
Journal:  Nature       Date:  1996-07-11       Impact factor: 49.962

Review 2.  The IFN gamma receptor: a paradigm for cytokine receptor signaling.

Authors:  E A Bach; M Aguet; R D Schreiber
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

3.  Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment.

Authors:  Nuno André Faustino; Thomas A Cooper
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

4.  Stat1 depends on transcriptional synergy with Sp1.

Authors:  D C Look; M R Pelletier; R M Tidwell; W T Roswit; M J Holtzman
Journal:  J Biol Chem       Date:  1995-12-22       Impact factor: 5.157

5.  Increased exon-trapping efficiency through modifications to the pSPL3 splicing vector.

Authors:  T C Burn; T D Connors; K W Klinger; G M Landes
Journal:  Gene       Date:  1995-08-19       Impact factor: 3.688

6.  Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling.

Authors:  J J Zhang; U Vinkemeier; W Gu; D Chakravarti; C M Horvath; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

7.  Regulation of interferon-alpha responsiveness by the duration of Janus kinase activity.

Authors:  C K Lee; H A Bluyssen; D E Levy
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

8.  Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle.

Authors:  Minghao Zhong; Melissa A Henriksen; Kenji Takeuchi; Olaf Schaefer; Bin Liu; Johanna ten Hoeve; Zhiyong Ren; Xiang Mao; Xiaomin Chen; Ke Shuai; James E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

9.  A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon.

Authors:  Xiao-Fei Kong; Guillaume Vogt; Ariane Chapgier; Christophe Lamaze; Jacinta Bustamante; Carolina Prando; Anny Fortin; Anne Puel; Jacqueline Feinberg; Xin-Xin Zhang; Pauline Gonnord; Ulla M Pihkala-Saarinen; Mikko Arola; Petra Moilanen; Laurent Abel; Matti Korppi; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova
Journal:  Hum Mol Genet       Date:  2009-10-31       Impact factor: 6.150

10.  A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice.

Authors:  Karine Turcotte; Susan Gauthier; Ashleigh Tuite; Alaka Mullick; Danielle Malo; Philippe Gros
Journal:  J Exp Med       Date:  2005-03-21       Impact factor: 14.307

View more
  47 in total

Review 1.  Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

Authors:  Roshini S Abraham; Geraldine Aubert
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

Review 2.  Mendelian susceptibility to mycobacterial disease: recent discoveries.

Authors:  Jacinta Bustamante
Journal:  Hum Genet       Date:  2020-02-05       Impact factor: 4.132

3.  A novel STAT1 mutation associated with disseminated mycobacterial disease.

Authors:  Elizabeth P Sampaio; Hannelore I Bax; Amy P Hsu; Ervand Kristosturyan; Joseph Pechacek; Prabha Chandrasekaran; Michelle L Paulson; Dalton L Dias; Christine Spalding; Gulbu Uzel; Li Ding; Elizabeth McFarland; Steven M Holland
Journal:  J Clin Immunol       Date:  2012-02-29       Impact factor: 8.317

Review 4.  Inborn errors of anti-viral interferon immunity in humans.

Authors:  Vanessa Sancho-Shimizu; Rebeca Perez de Diego; Emmanuelle Jouanguy; Shen-Ying Zhang; Jean-Laurent Casanova
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

Review 5.  Autoimmunity and primary immunodeficiency: two sides of the same coin?

Authors:  Reinhold E Schmidt; Bodo Grimbacher; Torsten Witte
Journal:  Nat Rev Rheumatol       Date:  2017-12-19       Impact factor: 20.543

6.  Long-Term Survival After Hematopoietic Stem Cell Transplantation for Complete STAT1 Deficiency.

Authors:  Samuele Naviglio; Elena Soncini; Donatella Vairo; Arnalda Lanfranchi; Raffaele Badolato; Fulvio Porta
Journal:  J Clin Immunol       Date:  2017-08-16       Impact factor: 8.317

7.  Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease.

Authors:  Xiao-Fei Kong; Guillaume Vogt; Yuval Itan; Anna Macura-Biegun; Anna Szaflarska; Danuta Kowalczyk; Ariane Chapgier; Avinash Abhyankar; Dieter Furthner; Claudia Djambas Khayat; Satoshi Okada; Vanessa L Bryant; Dusan Bogunovic; Alexandra Kreins; Marcela Moncada-Vélez; Mélanie Migaud; Sulaiman Al-Ajaji; Saleh Al-Muhsen; Steven M Holland; Laurent Abel; Capucine Picard; Damien Chaussabel; Jacinta Bustamante; Jean-Laurent Casanova; Stéphanie Boisson-Dupuis
Journal:  Hum Mol Genet       Date:  2012-11-16       Impact factor: 6.150

Review 8.  Incomplete penetrance in primary immunodeficiency: a skeleton in the closet.

Authors:  Conor Gruber; Dusan Bogunovic
Journal:  Hum Genet       Date:  2020-02-17       Impact factor: 4.132

9.  Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis.

Authors:  Osamu Hirata; Satoshi Okada; Miyuki Tsumura; Reiko Kagawa; Mizuka Miki; Hiroshi Kawaguchi; Kazuhiro Nakamura; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova; Yoshihiro Takihara; Masao Kobayashi
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

Review 10.  A genetic perspective on granulomatous diseases with an emphasis on mycobacterial infections.

Authors:  Un-In Wu; Steven M Holland
Journal:  Semin Immunopathol       Date:  2016-01-05       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.